Correlation Between Effector Therapeutics and Synlogic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Synlogic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Synlogic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and Synlogic, you can compare the effects of market volatilities on Effector Therapeutics and Synlogic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Synlogic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Synlogic.

Diversification Opportunities for Effector Therapeutics and Synlogic

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between Effector and Synlogic is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Synlogic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synlogic and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Synlogic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synlogic has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Synlogic go up and down completely randomly.

Pair Corralation between Effector Therapeutics and Synlogic

Given the investment horizon of 90 days Effector Therapeutics is expected to under-perform the Synlogic. In addition to that, Effector Therapeutics is 2.37 times more volatile than Synlogic. It trades about -0.16 of its total potential returns per unit of risk. Synlogic is currently generating about -0.02 per unit of volatility. If you would invest  255.00  in Synlogic on August 29, 2024 and sell it today you would lose (115.00) from holding Synlogic or give up 45.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy59.04%
ValuesDaily Returns

Effector Therapeutics  vs.  Synlogic

 Performance 
       Timeline  
Effector Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Effector Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Effector Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Synlogic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Synlogic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Synlogic is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Effector Therapeutics and Synlogic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Effector Therapeutics and Synlogic

The main advantage of trading using opposite Effector Therapeutics and Synlogic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Synlogic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synlogic will offset losses from the drop in Synlogic's long position.
The idea behind Effector Therapeutics and Synlogic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency